V Convención de la Profesión Médica

V Convención de la Profesión Médica April 2012. http://tacd-ip.org/wp-content/uploads/2012/04/FinalPaper-Time-for- the-EU-to-lead-on-new-innovation-models_April-16-TIMES-NEW-ROMAN.pdf. Block F, Keller M. Where do innovations come from? Transformation in the U.S. economy, 1970, 2006. Working Papers in Technology Governance an Economic Dynamics n.º 35. The Other Canon Foundation, Norway. Tallinn University of Technology, Tallinn. • Cantero J. TTIP, salmón transgénico y derecho a regular a favor de la Salud Pública. Blog JS Juristas de la Salud, 24.12.2015. • CESCR. Human Rights and intellectual property. 2001;E/C 12/2001/15. • CESCR. Committee on Economic, Social and Cultural Rights. General Comment n.º 17. The right of everyone to benefit from the protection of the moral and material interests resulting from any scientific, literary or artistic products of which he or she is the author (article 15, paragraph 1(c), of the Covenant). 2005. Council of Europe. Public health and the interests of the pharmaceutical industry: how to guarantee the primacy of public health interests? Parliamentary Assembly. Rapporteur: Ms Liliana Maury Pasquier. Doc 13869. 14 Sept 2015. • De Boer. Supplementary Protection Certificate for medicinal products. An assessment of European Regulation. Amsterdam: Vrije Universiteit; 2015 • DNDi. An innovative approach to R&D for neglected patients. Ten years of experience & lessons learned by DNDi. Drugs for Neglected Diseases initiative. January 2014. • DNDi. An alternative research and development strategy to deliver affordable treatments for hepatitis C patients. The Drugs for Neglected Diseases initiative’s hepatitis C drug development strategy based on patient needs, not profits. DNDi. April 2016. • EFPIA. The Pharmaceutical Industry in Figures. Key Data 2015. European Federation of Pharmaceutical Industries and Associations. 2015. • Efpia, PhRMA. The EU-US Transatlantic Trade and Investment Partnership (TTIP). Towards better outcomes for patients and economic growth. European Federation of Pharmaceutical Industrial Associations; Pharmaceutical Research and Manufacturers of America.